Showing results (301-310 of 2,133) with videos related to
Sort By:
Pageof 214
Neuroepidemiology|November 6, 2009
Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patientsWei-Chih Hsu, Amy Ming-Fang Yen, Horng-Huei Liou, et al.Neuroepidemiology|December 15, 2005
Hallucinations, cognitive decline, and death in Alzheimer's diseaseR S Wilson, Y Tang, N T Aggarwal, et al.Neuroepidemiology|January 1, 1986
Epidemiological aspects of multiple sclerosis: a comparative study of four centres in EuropeA J Prange, K Lauer, S Poser, et al.Neuroepidemiology|October 7, 2025
Dementia and Cancer: Unravelling Methodological Biases in a Population-Based CohortAmber P Selie, Kimberly D van der Willik, M Arfan Ikram, et al.Neuroepidemiology|September 29, 2025
Impact of Lifestyle Activity Engagement on Incident Disability: A Stratified Analysis by Cardiovascular Disease RiskFumio Sakimoto, Takehiko Doi, Sho Nakakubo, et al.Neuroepidemiology|January 10, 2026
Epidemiology of Amyotrophic Lateral Sclerosis in the Pays de la Loire, France: A 20-Year Study from a Centralized Diagnostic CenterMarie-Lou Chevet, Maelle Garnier, Marc Fadel, et al.Neuroepidemiology|January 10, 2026
The burden of multiple sclerosis in Japan from 1990 to 2021 and predictions to 2050 based on the Global Burden of Disease study 2021Ruochen Wang, Davide Cossu, Yuji Tomizawa, et al.Neuroepidemiology|January 10, 2026
Patterns of multimorbidity in persons with multiple sclerosis: Belgrade population registry dataGorica Maric, Tatjana Pekmezovic, Olivera Tamas, et al.Neuroepidemiology|December 23, 2025
Diverging Global Burden, Risk Factors, and Temporal Trends of Early-Onset and Late-Onset Dementia: A Comprehensive Analysis of the Global Burden of Disease Study 2021Lifang Li, Tara S R Chen, Dongfeng HuangNeuroepidemiology|April 27, 2025
Performance of a Modified Version of the Charlson Comorbidity Index in Predicting Multiple Sclerosis Disability AccrualSalvatore Iacono, Giuseppe Schirò, Paolo Aridon, et al.Pageof 214